New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
12:17 EDTXLNX, ISRG, AAPL, JNPR, MCD, PBYI, BAOn The Fly: Midday Wrap
The major stock indexes began the session mixed and remained that way at midday, with the Nasdaq leading and the Dow lagging. The tech-heavy Nasdaq has been helped by shares of Apple (AAPL) and Microsoft (MSFT), which are both higher following their earnings reports last night. The blue-chip Dow, meanwhile, has been weighed on by Boeing's (BA) slide following its report this morning and weakness in McDonald’s (MCD) following multiple analyst downgrades. ECONOMIC EVENTS: In the U.S., MBA's mortgage market index rose 2.4%, with a 0.3% rise in the purchase index and a 4.1% gain in the refinance index for the week ended July 18. Also, the International Monetary Fund predicted that U.S. economic growth for 2014 as a whole will be a disappointing 1.7%. However, barring unforeseen shocks, 2015 growth should accelerate to the fastest annual pace since 2005, propelled by strong consumption growth, a declining fiscal drag, a pickup in residential investment, and easy financial conditions, said the IMF. COMPANY NEWS: Shares of Apple advanced nearly 3% after reporting third quarter earnings that beat expectations. However, the iPhone maker's revenue came in a bit short of analyst expectations for its just completed quarter and its guidance for sales in the new quarter was also below expectations. Piper Jaffray analyst Gene Munster said Apple's September quarter guidance suggests an iPhone 6 launch on September 26, versus the firm's prior expectation for a September 19 launch. Piper views Apple's Q3 results as removing the last major variable ahead of the iPhone and iWatch launches later this year and reiterates an Overweight rating on the stock. Cantor, which said it believes that Apple's execution in Q3 was solid and that the company's Q4 guidance was "good enough," keeps a Buy rating on the stock and raised it price target on the shares to to $123 from $111... Dow component Boeing sank 2.5% near noon despite reporting "core" EPS that beat expectations and raising its fiscal year earnings outlook to a range above the Wall Street consensus. Boeing's revenue missed expectations, however, and it also reported its total company backlog of $440B was unchanged from the beginning of the quarter... Another Dow member, McDonald's, fell 1% after the company reported weaker than expected second quarter results yesterday and its stock was downgraded by at least five research firms. MAJOR MOVERS: Among the notable gainers was Puma Biotechnology (PBYI), whose stock almost tripled after the company reported positive data for its breast cancer drug and an analyst at Citigroup said that the company would probably become a takeover target. Also higher was Intuitive Surgical (ISRG), which rose almost 15% and was upgraded at both Raymond James and Stifel after the company reported better than expected Q2 results. Among the noteworthy losers following earnings reports that prompted downgrades were Xilinx (XLNX), which fell over 14%, and Juniper Networks (JNPR), which dropped 10%. INDEXES: Near midday, the Dow was down 23.81, or 0.14%, to 17,089.73, the Nasdaq was up 21.27, or 0.48%, to 4,477.29, and the S&P 500 was up 4.65, or 0.23%, to 1,988.18.
News For AAPL;BA;MCD;ISRG;PBYI;JNPR;XLNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | all recent news | >>
April 15, 2015
08:01 EDTAAPLApple services profit contribution rising, says UBS
Subscribe for More Information
07:46 EDTJNPREricsson, Juniper in focus for deals after Nokia-Alcatel tie-up, Bloomberg says
Subscribe for More Information
06:35 EDTAAPLSamsung says Galaxy S6 demand much stronger than expected, Reuters reports
Subscribe for More Information
06:18 EDTAAPLApple, Google, others doubling down on European operations, WSJ reports
Subscribe for More Information
06:14 EDTAAPLSamsung may be borrowing from Apple profit margin strategy, WSJ reports
Samsung (SSNLF) could be borrowing from Apple's (AAPL) profit margin strategy by charging customers $100 more for each incremental gain in storage capacity, reports the Wall Street Journal. IHS senior director of research and analytics Andrew Rassweiler said it costs Samsung makes an extra $87 in profit each time it sells a 64-gigabyte Galaxy S6 and an extra $160 each time it sells a 128-gigabye device. Rassweiler adds that Apple has been structuring its iPhone offerings like this for years to improve margins. Reference Link
06:04 EDTMCDMcDonald's initiated with a Market Perform at Cowen
Subscribe for More Information
05:55 EDTAAPLSmart wearaable device vendors avoid Apple Watch competition, DigiTimes says
Subscribe for More Information
April 14, 2015
19:48 EDTBABoeing union may cancel vote to unionize South Carolina workers, WSJ says
Subscribe for More Information
17:45 EDTAAPLApple acquires Israel-based camera-technology company LinX, WSJ says
Subscribe for More Information
16:00 EDTAAPLOptions Update; April 14, 2015
Subscribe for More Information
12:01 EDTAAPLApple says ResearchKit now available to medical researchers
Subscribe for More Information
10:27 EDTAAPLSamsung's Galaxy S6 Edge costliest phone to build, Re/code reports
Subscribe for More Information
09:43 EDTAAPLApple to discuss future of iOS and OS X at conference on June 8
Apple announced that it will hold its 26th annual Worldwide Developers Conference June 8 through June 12 at San Francisco’s Moscone West. At WWDC, Apple’s developer community will come together to learn about the future of iOS and OS X. WWDC will feature more than 100 technical sessions, over 1,000 Apple engineers, hands-on labs to help developers integrate technologies and fine tune their apps. Reference Link
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN PBR SU NFLX ALU BIDU TSLA JNJ GE
09:08 EDTBASouthwest selects seat for future Boeing aircraft
Subscribe for More Information
08:46 EDTPBYIPuma Biotechnology expands cohort in Phase II PB272 trial
Puma Biotechnology has expanded the second cohort from its Phase II clinical trial of its lead drug candidate PB272 as a single agent in patients with solid tumors who have an activating HER2 mutation. The cohort that has been expanded is the cohort that includes patients with metastatic non-small cell lung cancer and whose tumors have a HER2 mutation. The Phase II basket trial, which was initiated in October 2013, is an open-label, multicenter, multinational study to evaluate the safety and efficacy of PB272 administered daily to patients who have solid tumors with activating (driver) ERBB mutations, including epidermal growth factor receptor, HER2 and HER3. The cohorts (baskets) included in the study are (1) bladder/urinary tract cancer; (2) breast cancer; (3) colorectal cancer; (4) endometrial cancer; (5) gastric/esophageal cancer; (6) ovarian cancer; (7) all other solid tumors with a HER2 mutation; (8) EGFR mutated and/or amplified primary brain cancer; and (9) solid tumors with a HER3 mutation. The non-small cell lung cancer patients initially entered the study in the “other solid tumors with a HER2 mutation” basket and due to the preliminary activity seen in the trial the Company has expanded the basket, as per the protocol for the trial. The expanded HER2 mutant NSCLC basket will now enroll a total of 18 patients.
08:40 EDTAAPLSeveral signs suggest Apple may build a car, says Bernstein
Subscribe for More Information
07:10 EDTBAAviation Week to hold a conference
MRO Americas 2015 is being held in Miami Beach on April 14-16.
06:15 EDTBABoeing, Lockheed Martin JV unveils Vulcan rocket with reusable engine
Subscribe for More Information
05:48 EDTAAPLReport: Foxconn engaged in selling second-hand iPhones in China, DigiTimes says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use